Russell Frank Company’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Russell Frank Company’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$6.45M	Buy	45,016 +5,655	+14%	+$803K	0.01%	1185
2015 Q4	$6.09M	Buy	39,361 +9,731	+33%	+$1.42M	0.01%	1177
2015 Q3	$4.23M	Buy	29,630 +2,445	+9%	+$342K	0.01%	1372
2015 Q2	$3.9M	Buy	27,185 +15,557	+134%	+$2.22M	0.01%	1584
2015 Q1	$1.64M	Sell	11,628 -10,510	-47%	-$1.62M	﹤0.01%	1893
2014 Q4	$3.28M	Sell	22,138 -18,421	-45%	-$2.71M	0.01%	1524
2014 Q3	$6.24M	Buy	+40,559	New	+$6.11M	0.01%	1154

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCM

Greywolf Capital Management Purchase, New York $67.3M AUM 100.05% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Russell Frank Company's TARO Position: Q1 2016 in Review

Russell Frank Company increased its Taro Pharmaceutical Industries Ltd. (TARO) stake by 14% in Q1 2016, buying an estimated $803K and bringing the position to 45,016 shares worth $6.45M. The position accounts for 0.01% of the portfolio, ranked #1185.

Russell Frank Company first reported a position in TARO in Q3 2014 and has held it in 7 quarters since. 167 funds tracked by Wall St. Rank hold TARO as of Q1 2016.

Russell Frank Company held 45,016 shares of Taro Pharmaceutical Industries Ltd. worth $6.45M as of Q1 2016.
Russell Frank Company bought 5,655 Taro Pharmaceutical Industries Ltd. shares in Q1 2016, an estimated $803K.
Taro Pharmaceutical Industries Ltd. made up 0.01% of Russell Frank Company's portfolio in Q1 2016, its #1185 holding.
Russell Frank Company first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2014 and has held it in 7 quarters since.
167 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.